Do Wall Street Analysts Like Henry Schein Stock?

With a market cap of $8.4 billion, Henry Schein, Inc. (HSIC) is a leading global provider of healthcare products and services, primarily serving dental and medical practitioners. The New York-based company operates through a large distribution network, offering supplies, equipment, pharmaceuticals, and value-added solutions, such as practice management software, consulting, and digital dentistry technologies.

Shares of HSIC have underperformed the broader market over the past 52 weeks. HSIC stock has surged 7.4% over this time frame, while the broader S&P 500 Index ($SPX) has gained 13.2%. Moreover, shares of the company have climbed 3.2% on a YTD basis, compared to SPX's 14.5% rise.